Zawitz David, Chief Operating Officer of Verrica Pharmaceuticals Inc. ($VRCA), made one open market purchase of company shares in the last 365 days, totaling $42,425. His most recent buy occurred on November 25, 2025. This purchase ranks 3,189th among nearly 5,000 individual insiders in our database, where the average buy amounts to about 1.5 million dollars across 3.29 transactions. Zawitz David reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 25, 2025 | Verrica Pharmaceuticals Inc. | $VRCA | Zawitz David | Chief Operating Officer | P | Common Stock | 10000 | $4.24 | 21,000.0000 | 9,490,035 | 90.91% | 0.11% |
| Nov. 25, 2025 | Verrica Pharmaceuticals Inc. | $VRCA | Zawitz David | Chief Operating Officer | P | Series C Warrant (right to buy) | 2500 | $0.00 | 2,500.0000 | 9,490,035 | 9999.99% | 0.03% |
| Dec. 9, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Zawitz David | Chief Operating Officer | A | Employee Stock Option (right to buy) | 950000 | $0.00 | 950,000.0000 | 0 | 9999.99% | 0.00% |